Industry reports
Editor highlights

Search inside this page

All regions

Free Market Research Guides to Download

Biotechnology Analysis & Statistics in the United States, March 2011 (p20)

You might be interested in: biotech, biomedical, protein, more »

» Purchase Premium Reports

571-600 of about 900 reports
MedImmune, LLC. (formerly Cambridge Antibody Technology)-Detailed Product Pipeline

MedImmune, LLC. (formerly Cambridge Antibody Technology)-Detailed Product Pipeline

  • $ 750
  • Company report
  • March 2011
  • by Life Science Analytics (LSA)

MedImmune, LLC. (formerly Cambridge Antibody Technology)-Detailed Product Pipeline provides up to date insight into company's business description, product information, pipeline details including both ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Hawaii Biotech, Inc.-Detailed Product Pipeline

Hawaii Biotech, Inc.-Detailed Product Pipeline

  • $ 750
  • Company report
  • March 2011
  • by Life Science Analytics (LSA)

Hawaii Biotech, Inc.-Detailed Product Pipeline provides up to date insight into company's business description, product information, pipeline details including both summary information and detailed individual ...

  • Industries : Biotechnology
  • Countries : United States
OMRIX biopharmaceuticals LTD-Detailed Product Pipeline

OMRIX biopharmaceuticals LTD-Detailed Product Pipeline

  • $ 750
  • Company report
  • March 2011
  • by Life Science Analytics (LSA)

OMRIX biopharmaceuticals LTD-Detailed Product Pipeline provides up to date insight into company's business description, product information, pipeline details including both summary information and detailed ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Human Genome Sciences Inc-Detailed Product Pipeline

Human Genome Sciences Inc-Detailed Product Pipeline

  • $ 750
  • Company report
  • March 2011
  • by Life Science Analytics (LSA)

Human Genome Sciences Inc-Detailed Product Pipeline Report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent ...

  • Industries : Genomics
  • Countries : United States
Seattle Genetics Inc-Detailed Product Pipeline

Seattle Genetics Inc-Detailed Product Pipeline

  • $ 750
  • Company report
  • March 2011
  • by Life Science Analytics (LSA)

Seattle Genetics Inc-Detailed Product Pipeline Report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news ...

  • Industries : Genomics
  • Countries : United States
Accentia Biopharmaceuticals Inc-Detailed Product Pipeline

Accentia Biopharmaceuticals Inc-Detailed Product Pipeline

  • $ 750
  • Company report
  • March 2011
  • by Life Science Analytics (LSA)

Accentia Biopharmaceuticals Inc-Detailed Product Pipeline Report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and ...

  • Industries : Biopharmaceutical
  • Countries : United States
Seattle Genetics Inc-Therapeutic Competitors

Seattle Genetics Inc-Therapeutic Competitors

  • $ 350
  • Company report
  • March 2011
  • by Life Science Analytics (LSA)

Seattle Genetics Inc-Therapeutic Competitors Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed ...

  • Industries : Genomics
  • Countries : United States
Nabi Biopharmaceuticals-Detailed Product Pipeline

Nabi Biopharmaceuticals-Detailed Product Pipeline

  • $ 750
  • Company report
  • March 2011
  • by Life Science Analytics (LSA)

Nabi Biopharmaceuticals-Detailed Product Pipeline Report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent ...

  • Industries : Biopharmaceutical
  • Countries : United States
Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Raven biotechnologies, Inc.

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Raven biotechnologies, Inc.

  • $ 250
  • Company report
  • March 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : United States
Strategic Analysis of the U.S. Next Generation Sequencing Markets

Strategic Analysis of the U.S. Next Generation Sequencing Markets

  • $ 6 000
  • Industry report
  • March 2011
  • by Frost & Sullivan

This research service provides a strategic analysis of the next generation sequencing market. This study provides a detailed overview of the next generation sequencing instruments on the market, an analysis ...

  • Industries : Genomics
  • Countries : United States
Research Case : Personalized Cancer Therapy - The era of biomarker identification and companion diagnostic co-development

Research Case : Personalized Cancer Therapy - The era of biomarker identification and companion diagnostic co-development

  • $ 1 900
  • Industry report
  • March 2011
  • by Datamonitor

About This Report The treatment of cancer has seen a dramatic shift with the addition of molecular targeted therapies. The mixed and unpredictable responses to these targeted therapies are driving the ...

  • Industries : Biological Therapy
  • Countries : Japan, United States
Monoclonal Antibodies: A Segment of Major Growth

Monoclonal Antibodies: A Segment of Major Growth

  • $ 3 195
  • Industry report
  • March 2011
  • by CHI Insight Pharma Reports

Monoclonal antibodies are highly valuable therapeutic agents and were among the best-selling drugs in the world in 2010. Global revenues from monoclonal antibody products will have moved significantly ...

  • Industries : Biopharmaceutical
  • Countries : United States
What's For Dinner 2011: Trends in Center of Plate Proteins

What's For Dinner 2011: Trends in Center of Plate Proteins

  • $ 3 995
  • Industry report
  • March 2011
  • by Packaged Facts

Continuing behaviors adopted during the recession, American consumers are eating in more, which is beneficial to the fresh protein businesses of meat, poultry and seafood alike. However, consumers are ...

  • Industries : Sport Nutritional, Biotechnology
  • Countries : United States
Targeted Genetics Corporation (Symbol:TGEN) SWOT Analysis, Strategy, Revenues and Profits

Targeted Genetics Corporation (Symbol:TGEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • February 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : United States
Future Directions in Regenerative Medicine

Future Directions in Regenerative Medicine

  • $ 3 835
  • Industry report
  • February 2011
  • by SCRIP Insights

Big Pharma has begun investing in regenerative medicine: Genzyme in 2008, Pfizer and Novartis in 2009, and Cephalon in 2010. In 3-5 years, investment will reach a ?tipping point?, after which no medical ...

  • Industries : Biological Therapy
  • Countries : United States
US Stem Cells Research Industry

US Stem Cells Research Industry

  • $ 4 500
  • Industry report
  • February 2011
  • by Global Industry Analyst

This report analyzes the US Market for Stem Cells Research in US$ Million. Annual forecasts are provided for the period 2006 through 2015. The report profiles 92 companies including many key and niche ...

  • Industries : Biological Therapy
  • Countries : United States
Competitor Analysis Cancer Antibodies in Early Clinical Develoment

Competitor Analysis Cancer Antibodies in Early Clinical Develoment

  • $ 1 188
  • Industry report
  • February 2011
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Cancer Antibodies in Early Clinical Development provides a competitor evaluation in the field of antibody therapeutics being developed ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biomarkers in Parkinson`s Disease, 2011

Biomarkers in Parkinson`s Disease, 2011

  • $ 2 324
  • Industry report
  • January 2011
  • by BioPharm Reports

This report presents a comprehensive update on PD biomarker developments up to 2010. It covers the major classes of emerging and new markers relating to PD (blood, CSF, metabolomic, image-based, genetic ...

  • Industries : Genomics
  • Countries : United States
U.S. Preimplantation Genetic Diagnosis Market

U.S. Preimplantation Genetic Diagnosis Market

  • $ 6 000
  • Industry report
  • December 2010
  • by Frost & Sullivan

This research service analyzes the market for the preimplantation genetic diagnosis (PGD) market. Key market drivers and restraints are ranked and discussed. PGD revenue forecasts are modeled largely on ...

  • Industries : Genomics
  • Countries : United States
Biopharmaceutical Industry: Growth Hormone Deficiency - Pipeline Review, Q4 2010

Biopharmaceutical Industry: Growth Hormone Deficiency - Pipeline Review, Q4 2010

  • $ 500
  • Company report
  • December 2010
  • by Global Markets Direct

This report provides data on the therapeutic development for Growth Hormone Deficiency   , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions

Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions

  • $ 3 500
  • Industry report
  • December 2010
  • by GBI Research

Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions Summary GBI Research, the leading business intelligence provider, has released its latest ...

  • Industries : Biopharmaceutical
  • Countries : World, United States, Japan, Europe
Genomics Industry: NewLink Genetics Corporation - Product Pipeline Review - Q4 2010

Genomics Industry: NewLink Genetics Corporation - Product Pipeline Review - Q4 2010

  • $ 500
  • Company report
  • December 2010
  • by Global Markets Direct

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...

  • Industries : Genomics
  • Countries : United States, World
Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - Q4 2010

Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - Q4 2010

  • $ 500
  • Company report
  • December 2010
  • by Global Markets Direct

- Product Pipeline Review - Q4 2010? provides a detailed overview on the firm ?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Biopharmaceutical in United States: Inovio Pharmaceuticals, Inc. ? Product Pipeline Review - Q4 2010

Biopharmaceutical in United States: Inovio Pharmaceuticals, Inc. ? Product Pipeline Review - Q4 2010

  • $ 500
  • Company report
  • December 2010
  • by Global Markets Direct

- Product Pipeline Review - Q4 2010? provides a detailed overview on the firm ?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, ...

  • Industries : Biopharmaceutical
  • Countries : United States
Genetic Technologies Limited SWOT Analysis, Strategy, Revenues and Profits

Genetic Technologies Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • December 2010
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : United States
InNexus Biotechnology Inc. SWOT Analysis, Strategy, Revenues and Profits

InNexus Biotechnology Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • December 2010
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Canada, United States, United Kingdom
Talecris Biotherapeutics Holdings Corp SWOT

Talecris Biotherapeutics Holdings Corp SWOT

  • $ 175
  • Company report
  • December 2010
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Talecris Biotherapeutics Holdings (Talecris) is one ...

  • Industries : Biological Therapy
  • Countries : United States, Canada
U.S. Biopharmaceutical Market - Trends, Forecast, Competition & Strategic Analysis (2009 - 2016)

U.S. Biopharmaceutical Market - Trends, Forecast, Competition & Strategic Analysis (2009 - 2016)

  • $ 4 650
  • Industry report
  • December 2010
  • by MarketsandMarkets

Report Description This research report analyzes the U.S. biopharmaceuticals market and its growth factors, with special emphasis on the top companies in the field and their product pipeline. While it ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biological Therapy: Stem Cell Therapy Holds Promise for Ischemic Heart Disease Patients

Biological Therapy: Stem Cell Therapy Holds Promise for Ischemic Heart Disease Patients

  • $ 500
  • Company report
  • November 2010
  • by Global Data

What's inside this report? Industry expert's report, ?? provides key data, data on the scope of Stem Cell Therapy in cardiovascular disease. Research Scope - Data and data on the most commonly reprocessed ...

  • Industries : Biological Therapy
  • Countries : United States
Amgen: Pipeline - Products ? Performance - Potential

Amgen: Pipeline - Products ? Performance - Potential

  • $ 1 041
  • Company report
  • November 2010
  • by Espicom Business Intelligence

Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance ...

  • Industries : Biological Therapy
  • Countries : United States, Europe, Australia

» View Public Reports

About 2 400 reports

U.S. Genomics Business

  • Industry report
  • March 2014
  • 32 pages
  • by Research Paper

... Asia (91), africa (35), south america (9) and central america (47) were evaluated at genetic and phenotypic level to find genetic variation and important traits for oilseed production. Results ...


» Read our Company Profiles

22 Companies

Johnson and Johnson

United States

GlaxoSmithKline P.L.C.

United States

Biogen Idec

United States

Abbott Laboratories

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.